DK0720595T3 - Fremgangsmåde til adskillelse af to optiske antipoder ved krystallisation - Google Patents
Fremgangsmåde til adskillelse af to optiske antipoder ved krystallisationInfo
- Publication number
- DK0720595T3 DK0720595T3 DK94928427T DK94928427T DK0720595T3 DK 0720595 T3 DK0720595 T3 DK 0720595T3 DK 94928427 T DK94928427 T DK 94928427T DK 94928427 T DK94928427 T DK 94928427T DK 0720595 T3 DK0720595 T3 DK 0720595T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- enantiomer
- solution
- sec
- mother liquors
- Prior art date
Links
- 238000002425 crystallisation Methods 0.000 title abstract 3
- 230000008025 crystallization Effects 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 230000003287 optical effect Effects 0.000 title abstract 2
- 238000001816 cooling Methods 0.000 abstract 2
- 239000000243 solution Substances 0.000 abstract 2
- 239000013078 crystal Substances 0.000 abstract 1
- 239000010419 fine particle Substances 0.000 abstract 1
- 238000003306 harvesting Methods 0.000 abstract 1
- 238000000265 homogenisation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000012047 saturated solution Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B57/00—Separation of optically-active compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/74—Separation; Purification; Use of additives, e.g. for stabilisation
- C07C29/76—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment
- C07C29/78—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment by condensation or crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9311354A FR2710337B1 (fr) | 1993-09-23 | 1993-09-23 | Procédé de dédoublement de deux antipodes optiques par entraînement polythermique programmé et autoensemencé. |
| PCT/FR1994/001107 WO1995008522A1 (fr) | 1993-09-23 | 1994-09-22 | Procede de dedoublement de deux antipodes optiques par cristallisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0720595T3 true DK0720595T3 (da) | 1999-08-23 |
Family
ID=9451175
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94928427T DK0720595T3 (da) | 1993-09-23 | 1994-09-22 | Fremgangsmåde til adskillelse af to optiske antipoder ved krystallisation |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6022409A (ja) |
| EP (1) | EP0720595B1 (ja) |
| JP (1) | JP3647862B2 (ja) |
| AT (1) | ATE174889T1 (ja) |
| DE (1) | DE69415545T2 (ja) |
| DK (1) | DK0720595T3 (ja) |
| ES (1) | ES2128584T3 (ja) |
| FR (1) | FR2710337B1 (ja) |
| WO (1) | WO1995008522A1 (ja) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0008563D0 (en) * | 2000-04-07 | 2000-05-24 | Cambridge Discovery Chemistry | Investigating different physical and/or chemical forms of materials |
| FR2849029B1 (fr) | 2002-12-20 | 2005-03-18 | Lafon Labor | Procede de preparation et formes cristallines des enantiomeres optiques du modafinil. |
| US7368591B2 (en) | 2003-09-19 | 2008-05-06 | Cephalon France | Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation |
| US7501514B1 (en) | 2003-10-15 | 2009-03-10 | Shire Biochem, Inc. | Enantiomeric resolution of 2-substituted 4-substituted 1,3-oxathiolanes nucleosides |
| DE102005039501B4 (de) | 2005-08-20 | 2013-09-12 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Verfahren zur Trennung verbindungsbildender chiraler Systeme |
| JP2010503677A (ja) | 2006-09-15 | 2010-02-04 | シェーリング コーポレイション | 脂質代謝の障害を治療するためのアゼチジノン誘導体 |
| MX2009002924A (es) * | 2006-09-15 | 2009-05-28 | Schering Corp | Derivados de azetidinona espirociclica para el tratamiento de trastornos del metabolismo de los lipidos, el dolor, la diabetes y otros trastornos. |
| FR2909380B1 (fr) | 2006-12-04 | 2009-02-20 | Sidem Pharma Sa Sa | Conglomerats de sels de potassium de tenatoprazole |
| FR2920428B1 (fr) * | 2007-08-29 | 2012-06-15 | Univ Rouen | Procede de dedoublement de sels de l'omeprazole |
| KR101556815B1 (ko) * | 2008-09-05 | 2015-10-01 | 샤이어 캐나다 인코포레이티드 | 2,4-이치환된 1,3-옥사티올란 뉴클레오사이드의 거울상이성질체 분리 |
| US8992783B2 (en) | 2008-09-05 | 2015-03-31 | Max-Planck-Gessellschaft zur förderung der Wissenschaften e.V. | Process for enantioseparation of chiral systems with compound formation using two subsequent crystallization steps |
| ES2436633T3 (es) * | 2009-03-26 | 2014-01-03 | Poxel | Procedimiento para la separación de enantiómeros de dihidro-1,3,5-triazinas racémicas por cristalización preferencial |
| EP2292306B1 (en) * | 2009-09-02 | 2013-05-01 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Method for separation of racemic compound-forming chiral substances by a cyclic crystallization process and a crystallization device |
| FR2954310B1 (fr) * | 2009-12-18 | 2014-07-25 | Univ Rouen | Procede de dedoublement d'enantiomeres par evapocristallisation preferentielle |
| FR3054218B1 (fr) * | 2016-07-22 | 2020-03-06 | Universite De Rouen | Procede de dedoublement de sels de baclofene |
| CN116889627A (zh) | 2019-03-20 | 2023-10-17 | 雷杰纳荣制药公司 | 用固醇调节元件结合转录因子1(srebf1)抑制剂治疗脂质水平升高 |
| US11331332B2 (en) | 2019-03-20 | 2022-05-17 | Regeneron Pharmaceuticals, Inc. | Treatment of increased lipid levels with sterol regulatory element binding protein cleavage-activating protein (SCAP) inhibitors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1456627A (fr) * | 1964-07-24 | 1966-07-08 | Asahi Chemical Ind | Perfectionnements aux procédés pour la résolution de l'acide glutamique racémique et de ses sels |
| GB1197809A (en) * | 1968-02-13 | 1970-07-08 | Inst Noguchi | Method for Continuous Optical Resolution of Organic Racemates. |
-
1993
- 1993-09-23 FR FR9311354A patent/FR2710337B1/fr not_active Expired - Lifetime
-
1994
- 1994-09-22 AT AT94928427T patent/ATE174889T1/de active
- 1994-09-22 JP JP50960795A patent/JP3647862B2/ja not_active Expired - Lifetime
- 1994-09-22 WO PCT/FR1994/001107 patent/WO1995008522A1/fr active IP Right Grant
- 1994-09-22 US US08/619,477 patent/US6022409A/en not_active Expired - Lifetime
- 1994-09-22 ES ES94928427T patent/ES2128584T3/es not_active Expired - Lifetime
- 1994-09-22 DK DK94928427T patent/DK0720595T3/da active
- 1994-09-22 DE DE69415545T patent/DE69415545T2/de not_active Expired - Lifetime
- 1994-09-22 EP EP94928427A patent/EP0720595B1/fr not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO1995008522A1 (fr) | 1995-03-30 |
| ATE174889T1 (de) | 1999-01-15 |
| JP3647862B2 (ja) | 2005-05-18 |
| FR2710337B1 (fr) | 1995-12-08 |
| US6022409A (en) | 2000-02-08 |
| EP0720595A1 (fr) | 1996-07-10 |
| ES2128584T3 (es) | 1999-05-16 |
| FR2710337A1 (fr) | 1995-03-31 |
| EP0720595B1 (fr) | 1998-12-23 |
| DE69415545T2 (de) | 1999-09-16 |
| DE69415545D1 (de) | 1999-02-04 |
| JPH09506861A (ja) | 1997-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0720595T3 (da) | Fremgangsmåde til adskillelse af to optiske antipoder ved krystallisation | |
| ATE207036T1 (de) | Herstellung von aluminosilikatzeolithen | |
| DK289687A (da) | Fremgangsmaade til fremstilling af l-2-amino-4-(hydroxymethylphosphinyl)-smoeresyre | |
| DE60002679D1 (de) | Co-kristallisationsprozess | |
| FI924668A (fi) | Foerfarande foer framstaellning av vaesentligen ren melfalanhydroklorid | |
| ES8504683A1 (es) | Procedimiento de obtencion de un par enantiomerico de isomeros de cihalotrina | |
| DE3586017D1 (de) | Stabiles glukose-isomerase-konzentrat und verfahren zu dessen herstellung. | |
| RU2004137681A (ru) | Аддукт топирамата и гидрохлорида трамадола и его применения | |
| DE59405052D1 (de) | Verfahren zum herstellen von granulat | |
| DK0759973T3 (da) | Fremgangsmåde til klaring af vinase | |
| GEP19981257B (en) | Method of producing crystalline enantiomeric pair of isomers of (s)-alpha-cyano-3-phenoxybenzyl ester of (1r,cis)-3-(z-3-chlor-3,3,3)-trifluorprop-1-en-1-yl-2,2-dimethylcyclopropionic acid and (r)-alpha-cyano-3-phenoxybenzyl ester of (1s,cis9-3-(z-2-chlor-3,3,3-trifluorprop-1-en-1yl))-2,2-dimethylcyclopropionic acid | |
| KR850005404A (ko) | α-시아노-3-펜옥시-4-플루오로벤질 퍼메트레이트의 특정 에난티오머쌍의 제조방법 | |
| DE3060670D1 (en) | Process for the separation of the two optical isomers of 1-(o-methoxyphenoxy)-3-isopropylamino-propan-2-ol, optical isomers obtained thereby and pharmaceutical compositions of the levorotatory antipode thereof | |
| US2602047A (en) | Method of concentrating isotopic carbon | |
| ATE178051T1 (de) | Verfahren zur herstellung einer physikalisch stabilen, kristallinen gamma-modifikation von para-aminobenzolsulfonamid | |
| JPS5373507A (en) | Crystallization of pentaerythritol | |
| JPS5261665A (en) | Attaching method for parts | |
| JPS55115846A (en) | Optical resolution of dl-mandelic acid | |
| NZ239435A (en) | Conversion of the r(-) isomer of ketoprofen to the s(+) isomer | |
| GB1020696A (en) | Resolution of a salt of n-benzoyl serine | |
| JPS56158792A (en) | Preparation of amineborane | |
| AR247877A1 (es) | Procedimiento para preparar desoxiespergualina triclorhidrato cristalizado bajo la forma beta. | |
| JPS5387985A (en) | Gaseous phase epitaxial growth method for compound semiconductor crystal | |
| US20110263896A1 (en) | Process for Enantioseparation of Chiral Systems with Compound Formation Using Two Subsequent Crystallization Steps | |
| ES306210A3 (es) | Un procedimiento para concentrar soluciones que contienen un componente volatil |